TANG CAPITAL MANAGEMENT LLC Portfolio Holdings - 13F Filings | 13F Fund Database
TANG CAPITAL MANAGEMENT LLC 13F Holdings
CIK 0001232621 · SAN DIEGO, CA
As of Sep 30, 2025, TANG CAPITAL MANAGEMENT LLC reported
194 positions worth $2.6B in its SEC Form 13F filing.
Top 25 holdings
| Security | Ticker | Sector | Shares | Value | % of portfolio |
| TARSUS PHARMACEUTICALS INC | TARS | Healthcare | 2,454,797 |
|
45.9M
5.62% |
| GALAPAGOS NV | GLPG | Healthcare | 4,151,194 |
43.8M | 5.54% |
| AURINIA PHARMACEUTICALS INC | AUPH | Healthcare | 11,329,500 |
25.2M | 4.82% |
| PTC THERAPEUTICS INC | PTCT | Healthcare | 1,500,000 | $92.1M | 3.54% |
| MIRUM PHARMACEUTICALS INC | MIRM | Healthcare | 1,236,027 | $90.6M | 3.49% |
| KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | KNSA | Healthcare | 2,328,609 | $90.4M | 3.48% |
| IMMUNOCORE HOLDINGS PLC | IMCR | Healthcare | 2,305,608 | $83.8M | 3.22% |
| KALVISTA PHARMACEUTICALS INC | KALV | Healthcare | 5,041,798 | $61.4M | 2.36% |
| VIRIDIAN THERAPEUTICS INC | VRDN | Healthcare | 2,842,925 | $61.4M | 2.36% |
| COMPASS THERAPEUTICS INC | CMPX | Healthcare | 16,811,963 | $58.8M | 2.27% |
| CELCUITY INC | CELC | — | 1,150,000 | $56.8M | 2.19% |
| MERUS NV | MRUS | Healthcare | 600,000 | $56.5M | 2.17% |
| SPYRE THERAPEUTICS INC | SYRE | Healthcare | 3,200,000 | $53.6M | 2.06% |
| RELAY THERAPEUTICS INC | RLAY | Healthcare | 8,068,058 | $42.1M | 1.62% |
| LENZ THERAPEUTICS INC | LENZ | Healthcare | 897,616 | $41.8M | 1.61% |
| ANAPTYSBIO INC | ANAB | Healthcare | 1,333,639 | $40.8M | 1.57% |
| PRECIGEN INC | PGEN | Healthcare | 12,400,000 | $40.8M | 1.57% |
| VERA THERAPEUTICS INC | VERA | Healthcare | 1,350,000 | $39.2M | 1.51% |
| NIKE INC | NKE | Consumer Cyclical | 519,399 | $36.2M | 1.39% |
| IONIS PHARMACEUTICALS INC | IONS | Healthcare | 550,000 | $36.0M | 1.39% |
| CYTOMX THERAPEUTICS INC | CTMX | Healthcare | 11,065,662 | $35.3M | 1.36% |
| EVOLUS INC | EOLS | Healthcare | 5,488,299 | $33.7M | 1.30% |
| AVADEL PHARMACEUTICALS PLC | AVDL | Healthcare | 2,097,500 | $32.0M | 1.23% |
| ACADIA PHARMACEUTICALS INC | ACAD | Healthcare | 1,500,000 | $32.0M | 1.23% |
| VERTEX PHARMACEUTICALS INC | VRTX | Healthcare | 80,000 | $31.3M | 1.21% |